ArticleCureus2025
Delayed Hemothorax Following Trauma in a COVID-19 Positive Patient Requiring Video-Assisted Thoracoscopic Surgery: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delayed hemothorax (DHTX) is a possible sequelae of thoracic trauma, especially in the setting of patients being treated with anticoagulation. We report the case of an 81-year-old Caucasian man with a DHTX presenting 14 days following an initial emergency department (ED) visit with multiple rib fractures due to a fall from the patient's bed. Upon presentation to the ED a second time, the patient was hospitalized, tested positive for COVID-19, and on the second day of admission underwent video-assisted thoracoscopic surgery (VATS) without bleeding or other complications. This case illustrates that the initial weeks following thoracic trauma present a critical time window during which monitoring for complications such as spontaneous or DHTX can be beneficial, especially in patients being treated with anticoagulant medication. VATS is safe in patients who can tolerate single-lung anesthesia and provides a less invasive way to resolve the underlying pathology while providing comparable or even improved clinical outcomes, and should be considered when treating patients with hemothorax.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.